This is investing. Look at what the share price was when people (myself included) were saying those mean things about the company. $0.10-$0.20. Fast forward to now. It's trading at the equivalent of $0.01. So yeh, I'd say those people saying the company isn't for real were pretty justified and probably should have been listened to.
1. The company has funding for the next two years of research. - They've been funded for the past 7 years; hasn't gotten them anything. 2. We are trading on an exchange that provides FAR greater liquidity and access to institutional investors. - They got listed; they won't stay listed 3. The company is now around 40 to 50 percent owned by funds and accredited investors. - That is because of toxic dilution and screwing over retail investors; this is not something to be proud of 4. The company has a very competent PR/IR firm working to attract new investors. - How many PR's have we seen in the past year and a half that didn't involve diluting investors' share value? 5. The company is currently applying or has applied for fast track and approval for human trials. - This is completely fabricated; you have absolutely no evidence that this is true. You suspect it, but you cannot back up this claim.
Trust me, I'll bump this in May. I really do get entertained by how eloquently the goal posts can be moved.
Market Data 
Markets 
AI
